Medical aspects and applications of humic substances

The most-cited reference in the CPI knowledge graph. This book chapter, published in the Wiley-VCH reference volume “Biopolymers for Medical and Pharmaceutical Applications,” provides the pharmacological framework that most subsequent peat therapy research builds on. With 139 citations, it is the standard starting point for any scientific discussion of humic substance bioactivity.

What It Covers

Klöcking and Helbig systematically review three areas of medical activity: anti-inflammatory properties (cytokine suppression, immune modulation), antiviral activity (inhibition of viral replication, particularly HSV and HIV envelope binding), and antimicrobial effects (bacterial growth inhibition across gram-positive and gram-negative strains). The review does not focus on peat specifically — it covers humic substances as a class, drawing from agriculture, soil science, and pharmaceutical research as well as balneology.

Why It’s Foundational

Before Klöcking and Helbig, the evidence for humic substance bioactivity was scattered across German-language balneological literature and agricultural chemistry. This chapter consolidated that knowledge in English, in a pharmaceutical reference book, using pharmacological language that clinical researchers could work with. It established humic acids not as vague “natural extracts” but as compounds with defined receptor interactions and measurable dose-response effects.

Limitations to Note

As a review chapter rather than an original study, it does not report primary experimental data. The evidence grade reflects the quality of the underlying studies reviewed, which range from in vitro to small clinical observations. The chapter also covers synthetic and pharmaceutical humic substances alongside naturally occurring ones — the findings do not always translate directly to peat in cosmetic or balneological use.